Market Closed -
Other stock markets
|
After market 06:00:10 pm | |||
34.46 USD | -1.96% | 33.70 | -2.22% |
05:14pm | Leerink Partners Adjusts Moderna Price Target to $27 From $31, Maintains Underperform Rating | MT |
01:09pm | Stocks Gain Pre-Bell Ahead of Latest PPI Report; Asia, Europe Strong | MT |
1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
22 | |||||||||
20 | |||||||||
24 | |||||||||
21 | |||||||||
16 | |||||||||
14 | |||||||||
13 | |||||||||
10 | |||||||||
17 | |||||||||
19 | |||||||||
14 | |||||||||
19 | |||||||||
25 | |||||||||
17 | |||||||||
11 | |||||||||
- | 9 | ||||||||
8 | |||||||||
13 | |||||||||
7 | |||||||||
Average | 16 | ||||||||
Weighted average by Cap. | 18 |
- Stock Market
- Equities
- MRNA Stock
- Sector Moderna, Inc.
- Sector revisions